Yeast (Candida Species) Susceptibility Testing – Dubai, UAE | 150 AED

Executive Summary & Core Metrics

Core Metrics

✓ 99.9% Diagnostic Accuracy – Sensitivity and specificity achieved via ISO 9001:2015 certified, DHA-accredited laboratory (Cert: INT/EGQ/2509DA/3139).

✓ Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Secure medical courier for solid tissue specimen retrieval.

✓ Post-Result Clinical Teleconsultation – Provided by our licensed physicians to interpret results and guide antifungal therapy.

✓ Insurance Verification via WhatsApp – Send your insurance card to +971 54 548 8731 for instant pre-authorisation, in compliance with Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019.

Test Overview & Methodology

Yeast (Candida) susceptibility testing identifies which antifungal agents will effectively treat a patient’s specific Candida infection. Using rapid automated broth microdilution technology compliant with CLSI/EUCAST guidelines, the test determines the minimum inhibitory concentration (MIC) for each antifungal, enabling targeted therapy and preventing resistance.

Feature	Our Test (DHA-Accredited Lab)	Standard Manual Susceptibility
Precision	99.9% Diagnostic Sensitivity & Specificity via AI-assisted VITEK® 2 / YeastOne® panel	Variable; lab-dependent manual reading, higher error risk
Methodology	Rapid automated broth microdilution (CLSI/EUCAST compliant) with digital MIC analysis	Manual broth microdilution or disk diffusion, subjective interpretation
Speed (TAT)	3-day report from received positive culture (courier retrieval included)	5–7 working days, no guaranteed transport

Physician Insight & Safety Protocols

“While this test provides critical antifungal susceptibility data, results must be interpreted in conjunction with clinical presentation, site of infection, and patient immune status. I advise patients never to self-adjust medication without professional guidance, as resistance patterns can be complex.”

— Dr. Ajay Singh, General Practitioner, DHA License No. 36234132

Medication Safety Advisory

Do not discontinue prescribed antifungal medication without consulting your doctor. Abrupt discontinuation may lead to treatment failure or recurrence.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Positive culture plate not received in a sterile, leak-proof container; specimen frozen or maintained at room temperature >2 hours; patient with severe bleeding disorder that prevents safe courier collection of biological material.
Emergency Red Flags (seek immediate medical attention): Signs of invasive candidiasis or systemic inflammatory response — fever >38.5°C, tachycardia, hypotension, altered mental status; do not wait for susceptibility results.

Patient FAQ & Clinical Guidance

1. What is the yeast susceptibility test used for?

This test identifies which antifungal medications will most effectively treat your Candida infection, avoiding ineffective therapy and resistance development. It provides the minimum inhibitory concentration (MIC) of each antifungal against the exact Candida species grown from your culture, allowing your physician to select targeted treatment.

2. Is fasting or special preparation needed before the test?

No patient preparation is necessary. The test is performed on a pre-existing positive culture isolate from your previous specimen. Simply ensure your healthcare facility packages the culture plate in a sterile, leak-proof container and keeps it refrigerated until our courier collects it.

3. Will my health insurance cover this test?

Direct insurance billing is verified instantly via WhatsApp at +971 54 548 8731; we coordinate prior approvals with all major UAE insurers. Send a photo of your insurance card for pre-authorisation in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection and Federal Law No. 2 of 2019.

UAE Regulatory & Data Privacy Adherence

Your data is protected under UAE law. This laboratory strictly adheres to:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governs the collection, processing, and storage of your personal information.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensures secure electronic health data handling.
Federal Decree-Law No. 4 of 2016 on Medical Liability – governs clinical testing safety and patient consent.

ISO 9001:2015 Certified Laboratory | Cert: INT/EGQ/2509DA/3139 | MOHAP Code: 9834453

Clinical & Logistical Metadata

Test Name	Yeast (Candida Species) Susceptibility Testing
Price (AED)	150
Turnaround Time	3 business days from receipt of positive culture isolate
Sample Type / Matrix	Positive Candida culture isolate (solid culture plate or broth); hospital extraction only
Methodology Used	Rapid automated broth microdilution (CLSI/EUCAST compliant) with digital MIC analysis
ICD-10-CM Code	B37.9 (Candidiasis, unspecified); B37.8 (Candidiasis of other sites); B37.0 (Candidal stomatitis)
LOINC Code	20874-1 (Susceptibility Test result for Yeast)
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE)